<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-2HWDY83W/f-230-2-4d4e4d79-5ce7822d9d587eec9f5/PDF"><dcterms:extent>1115 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-2HWDY83W/949d5152-4bf2-4acd-b71b-98e3b4975c02/TEXT"><dcterms:extent>24 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="2022-2025"><edm:begin xml:lang="en">2022</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-2HWDY83W"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-UCB4A42Q" /><dcterms:issued>2022</dcterms:issued><dc:creator>Vehar, Lana</dc:creator><dc:format xml:lang="sl">številka:1</dc:format><dc:format xml:lang="sl">str. 31-35</dc:format><dc:identifier>COBISSID_HOST:122892803</dc:identifier><dc:identifier>ISSN:2820-5014</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-2HWDY83W</dc:identifier><dc:language>en</dc:language><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Fakulteta za farmacijo, ŠSSFD</dc:publisher><dcterms:isPartOf xml:lang="sl">Placebo</dcterms:isPartOf><dc:subject xml:lang="en">autoimmune pancreatitis</dc:subject><dc:subject xml:lang="sl">Avtoimunske bolezni</dc:subject><dc:subject xml:lang="sl">avtoimunski pankreatitis</dc:subject><dc:subject xml:lang="sl">biološki označevalci</dc:subject><dc:subject xml:lang="en">biomarkers</dc:subject><dc:subject xml:lang="en">chronic pancreatitis</dc:subject><dc:subject xml:lang="en">corticosteroids</dc:subject><dc:subject xml:lang="en">diagnostics</dc:subject><dc:subject xml:lang="sl">Diagnostika</dc:subject><dc:subject xml:lang="en">histopathological findings</dc:subject><dc:subject xml:lang="sl">histopatologija</dc:subject><dc:subject xml:lang="en">imaging</dc:subject><dc:subject xml:lang="en">inflammatory markers</dc:subject><dc:subject xml:lang="sl">kortikosteroidi</dc:subject><dc:subject xml:lang="sl">Kronični pankreatitis</dc:subject><dc:subject xml:lang="sl">slikovne preiskave</dc:subject><dcterms:temporal rdf:resource="2022-2025" /><dc:title xml:lang="sl">Diagnostika avtoimunskega pankreatitisa|</dc:title><dc:description xml:lang="sl">Autoimmune pancreatitis is a recently discovered, rare form of pancreatitis and is one of the medically curable diseases of the pancreas. Diagnostic criteria for autoimmune pancreatitis include a combination of imaging techniques, laboratory tests, histopathology, involvement of other organs, and response to corticosteroid treatment. Endoscopic ultrasound-guided needle biopsy of the pancreas is becoming increasingly important in the diagnosis of autoimmune pancreatitis because it allows for a complete examination of the upper gastrointestinal system and exclusion of malignant tumours. Treatment with corticosteroids should be initiated only when the diagnosis is clear, and histologically confirmed and after exclusion of adenocarcinoma</dc:description><dc:description xml:lang="sl">Avtoimunski pankreatitis je nedavno odkrita redka oblika pankreatitisa in predstavlja eno od bolezni trebušne slinavke, ki jo je mogoče zdraviti z zdravili. Diagnostična priporočila za avtoimunski pankreatitis vključujejo slikovne preiskave, laboratorijske teste in histopatološki pregled v povezavi z odkrivanjem pridruženih bolezenskih stanj in avtoimunskih bolezni ter proučevanjem odziva na zdravljenje s kortikosteroidi. Pri diagnosticiranju avtoimunskega pankreatitisa je vse pomembnejša z endoskopskim ultrazvokom vodena igelna biopsija trebušne slinavke, saj omogoči celoten pregled zgornjega gastrointestinalnega sistema in izključevanje malignih tumorjev. Zdravljenje s kortikosteroidi je utemeljeno samo pri jasni, histološko potrjeni diagnozi in izključenem adenokarcinomu</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-2HWDY83W"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-2HWDY83W" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-2HWDY83W/f-230-2-4d4e4d79-5ce7822d9d587eec9f5/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:dataProvider xml:lang="en">National and University Library of Slovenia</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-2HWDY83W/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-2HWDY83W" /></ore:Aggregation></rdf:RDF>